Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New oxytocin antagonists and their use in preterm labor, dysmenorrhea, etc.

July 23, 2003

NNC-77-0074 stimulates insulin release and inhibits glucagon secretion

July 23, 2003

Rosiglitazone beneficial in the treatment of HIV-related lipodystrophy

July 22, 2003

Orexin-1 antagonists and their use in obesity, sleep disorders, etc.

July 22, 2003

ICA-17043 ameliorates RBC dehydration in murine model of anemia

July 22, 2003

Strong antidiabetic effects reported for exenatide in patients with type 2 diabetes

July 22, 2003

New low doses of Premarin approved for prevention of postmenopausal osteoporosis

July 21, 2003

Zentaris prepares and tests new GnRH antagonists

July 21, 2003

Three related series of PPARalpha agonists patented by AstraZeneca researchers

July 21, 2003

Novel lipid-lowering TRbeta1-selective agonists described by BMS

July 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...